Artlin™

Artlin Global builds biotech founders — and the platforms they lead. At Artlin Global, we architect therapeutic systems that work — from RNA strategy and delivery design to global lab execution and capital alignment. Our approach combines platform intelligence, founder development, and a lab-enabled backend capable of transfection reagent production, preclinical formulation, and IND-aligned strategy. With partners across continents, we don’t just advise — we build with you. At the core: we solve delivery. Most gene therapies fail — not because the science is wrong, but because delivery systems don’t translate. We fix that bottleneck and design therapeutic platforms that are scalable, fundable, and execution-ready. Biomedical Innovation, our flagship signal channel, powers the next generation of biotech founders — and feeds directly into the Artlin Launch Studio™, our platform acceleration pathway. Whether you’re building from the bench, the boardroom, or the fund — we help you scale with clarity. Core Capabilities: • RNA Strategy™ (siRNA, mRNA, CRISPR) • Therapeutic Platform Design • Lab-Enabled Delivery Development • Founder Acceleration & Capital Alignment • IP Architecture & Licensing Strategy Founder-Led • Lab-Enabled • Strategy-Driven Artlin Global — Architecting Biotech Futures™ 📩 artlinhealth@gmail.com